Skip to main content
OpenTrials

Clinical trial condition

Spinal Muscular Atrophy Type 2

Explore clinical trials studying Spinal Muscular Atrophy Type 2. Study availability and eligibility vary by location and protocol.

5 public trials 1 recruiting study

Spinal Muscular Atrophy Type 2 trial results

Conditions
Anti-myostatin, Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +17 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Children's Hospital of Orange County (CHOC) Orange, California, United States
  • Stanford Neuroscience Health Center (SNHC) Palo Alto, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
View all 25 locations
Conditions
Anti-myostatin, Atrophy, Central Nervous System Diseases, +20 more
Locations
  • Children's of Alabama Birmingham, Alabama, United States
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Children's Hospital of Los Angeles Los Angeles, California, United States
  • Stanford University Medical Center Palo Alto, California, United States
View all 50 locations
Conditions
Atrophy, Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +19 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Stanford University Palo Alto, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • The Johns Hopkins University Baltimore, Maryland, United States
View all 16 locations
Conditions
Anti-myostatin, Atrophy, Central Nervous System Diseases, +20 more
Locations
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • UCSD Altman Clinical and Translational Research La Jolla, California, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Stanford Neuroscience Health Center Palo Alto, California, United States
View all 49 locations